Characterization of the Transport of a Cationic Octapeptide, Octreotide, In Rat Bile Canalicular Membrane : Possible Involvement of P-Glycoprotein

スポンサーリンク

概要

• 論文の詳細を見る

• The cyclic cationic octapeptide octreotide is known to be taken up by hepatocytes, with more than 70% of an intravenous dose being excreted into bile in unchanged form. We have already reported that a transporter other than the canalicular multispecific organic anion transporter (cMOAT) is responsible for the biliary excretion of octreotide in vivo. The aim of this study is to obtain an insight into the transporter of octreotide in bile canalicular membrane. The effect of various compounds on the ATP-dependent uptake of octreotide by rat bile canalicular membrane vesicles (CMV) was investigated. The ATP-dependent uptake of [^<14>C] octreotide by CMV was inhibited by verapamil, vincristine and PSC833 in a concentration-dependent manner, tha maximum inhibitory effects of these compounds being almost equal to that of excess unlabeled octreotide, while taurocholic acid (TCA) caused no inhibition at concentrations much higher than the K_m of TCA uptake by CMV. Mutual inhibition between octreotide and dinitrophenylglutathione (DNP-SG), a representative substrate for cMOAT was only minor and could only be observed at concentrations much higher than the K_m for each ligand uptake. To examine the contribution of P-glycoprotein to the biliary excretion of octreotide in vivo, biliary excretion of octreotide was compared between P-glycoprotein-induced rats by phenothiazine (PTZ) treatment and normal rats. A significant increase in the biliary excretion rate was observed in PTZ-treated rats. Only a slight decrease in biliary excretion was observed in mdr1a knock-out mice compared with noraml mice, which may be explained by the associated induction of mdr1b. These results demonstrate that the transporter for octreotide is different from cMOST and the bile acid transporter. The involvement of P-glycoprotein in the biliary excretion of octreotide is suggested.

• 公益社団法人日本薬学会の論文
• 1998-08-15

著者

• SUGIYAMA Yuichi

  Graduate School of Pharmaceutical Sciences, The University of Tokyo

• KATO Yukio

  Graduate School of Pharmaceutical Sciences, University of Tokyo

• Lemaire Michel

  Novartis Ltd.

• Kato Yukio

  Graduate School Of Pharmaceutical Sciences University Of Tokyo

• KUSUHARA Hiroyuki

  Graduate School of Pharmaceutical Sciences, the University of Tokyo

• Kusuhara Hiroyuki

  Graduate School Of Pharmaceutical Sciences The Univ. Of Tokyo

• Kusuhara Hiroyuki

  Graduate School Of Pharmaceutical Sciences University Of Tokyo

• YAMADA Tadashi

  Graduate School of Pharmaceutical Sciences, University of Tokyo

• Kato Yukio

  Graduate School Of Natural Science And Technology Kanazawa University

• Sugiyama Yuichi

  Graduate School Of Pharmaceutical Sciences The University Of Tokyo

• Yamada Tadashi

  Graduate School Of Pharmaceutical Sciences University Of Tokyo

• Sugiyama Yuichi

  Graduate School Of Pharmaceutical Sciences The Univ. Of Tokyo

関連論文

• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
• Effect of Aminoguanidine on Lipopolysaccharide-Induced Changes in Rat Liver Transporters and Transcription Factors(Molecular and Cell Biology)
• Function of Uptake Transporters for Taurocholate and Estradiol 17β-D-Glucuronide in Cryopreserved Human Hepatocytes
• Potential Cholestatic Activity of Various Therapeutic Agents Assessed by Bile Canalicular Membrane Vesicles Isolated from Rats and Humans
• The Potential for an Interaction between MRP2 (ABCC2) and Various Therapeutic Agents : Probenecid as a Candidate Inhibitor of the Biliary Excretion of Irinotecan Metabolites
• 22D-11-2 Modifying the pharmacokinetics of the anticancer drug CPT-11, and its active metabolite SN-38, aimed at reducing the biliary excretion of SN-38 and its gastrointestinal toxicity.
• Quantitative Prediction of In Vivo Drug-drug Interactions from In Vitro Data : Effects of Active Transport of Inhibitors into the Liver
• Differences in Substrate Specificity among Glutathione Conjugates (GS-X) Pump Family Members: Comparison between Multidrug Resistance-associated Protein and a Novel Transporter Expressed on a Cisplatin-resistant Cell Line (KCP-4)
• Carrier-Mediated Uptake of Grepafloxacin, a Fluoroquinolone Antibiotic, by the Isolated Rat Lung Cells
• Nitric Oxide and Peroxynitrite Regulate Transporter Transcription in Rat Liver Slices(Molecular and Cell Biology)
• High-Speed Data Position Detection Method Using Template Matching for Hologram Memory
• Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
• Evaluation of Methods for Prediciting Drug-drug Interactions by Monte Carlo Simulation
• Lack of Contribution of P-Glycoprotein (P-gp) to Transport via the Mouse Blood-Cerebrospinal Fluid Barrier
• The role of breast cancer resistance protein, Bcrp in the transport of estrone-3-sulfate and dehydroepiandrosterone sulfate across the blood-brain barrier
• In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
• Characterization of the Transport of a Cationic Octapeptide, Octreotide, In Rat Bile Canalicular Membrane : Possible Involvement of P-Glycoprotein
• Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
• Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry
• Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring
• The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotein-Quantitative Analysis Based on Information from the Literature
• Anti-metastatic Effect of the Sialyl Lewis-X Analog GSC-150 on the Human Colon Carcinoma Derived Cell Line KM12-HX in the Mouse
• Prediction of Interindividual Variability in Pharmacokinetics for CYP3A4 Substrates in Humans
• Estimation of the Interindividual Variability of Cytochrome 2D6 Activity from Urinary Metabolic Ratios in the Literature
• Drug-drug interaction based on the inhibition on the transporter-mediated hepatic uptake (DRUG METABOLISM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Role of OATP transporter family in the hepatic uptake of pitavastatin (LIVER/DIGESTIVE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Pharmacokinetics and Mechanism of Intestinal Absorption of JBP485 in Rats
• Xenobiotic Transporter-Adaptor Network
• Species Difference in Nisoldipine Oxidation Activity in the Small Intestine
• First automatic radiosynthesis of ^C labeled Telmisartan using a multipurpose synthesizer for clinical research use
• Characterization of efflux transporters in the net uptake of dehydroepiandrosterone sulfate and mitoxantrone via the blood-brain barrier in the mouse (第25回生体膜と薬物の相互作用シンポジウム--ダイナミックインターフェイスとしての生体膜 講演要旨集)
• High-Speed Data Position Detection Method Using Template Matching for Hologram Memory
• Drug Transporters : Their Role and Importance in the Selection and Development of New Drugs
• Effective Use of Microdosing and Positron Emission Tomography (PET) Studies on New Drug Discovery and Development

もっと見る 閉じる

スポンサーリンク